Terashima, Takeshi
Morizane, Chigusa https://orcid.org/0000-0002-6560-7503
Chida, Akihiko
Todaka, Akiko
Umemoto, Kumiko
Kawakami, Yujiro
Yamashita, Tatsuya
Ueno, Makoto
Furuse, Junji
Nagano, Hiroaki
Article History
Received: 15 May 2025
Accepted: 2 October 2025
First Online: 19 October 2025
Declarations
:
: Takeshi Terashima and Junji Furuse received lecture fees from Astrazeneca K.K., and Makoto Ueno received research fundings from Taiho Pharmaceutical Co., Ltd., AstraZeneca, K.K, MSD K.K, Nihon Servier Co., Ltd., Ono Pharmaceutical Co., Ltd., Incyte Biosciences Japan GK, Chugai Pharmaceutical Co., Ltd., Boehringer Ingelheim GmbH, Eisai Co., Ltd., Novartis Pharma K.K, Astellas Pharma Inc., J-pharma Co., Ltd., DFP (Delta Fly Pharma), Inc., Novocure GmbH, and Chiome Bioscience Inc..